Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Recurrent Ovarian High Grade Serous Adenocarcinoma · Recurrent Platinum-Resistant Ovarian Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Sami Dwabe)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Anastasia Martynova)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Anastasia Martynova)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Sami Dwabe)
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

  • Northwestern University, Chicago, Illinois, United States

  • University of Kansas Clinical Research Center, Fairway, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Andrea D. Jewell)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

  • University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States

  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Andrea E. Wahner Hendrickson)
  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

  • University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States

  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Janelle Darby)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (John L. Hays)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Lauren E. Dockery)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Mitchell I. Edelson)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Alaina J. Brown)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Linda R. Duska)
מובילי המחקר
  • Camille Jackson

    Principal Investigator

    Yale University Cancer Center LAO